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The formation of a permeability barrier between the external 
environment and the host is essential for survival. To provide 
this barrier keratinocytes undergo a complex pathway of 
differentiation, which culminates in keratinocyte cornification 
and the formation of extracellular lipid enriched lamellar 
membranes in the stratum corneum. The mechanisms that 
coordinately regulate the parallel formation of the corneocytes 
and lamellar membranes are unknown. The extracellular 
lamellar membranes are derived from the exocytosis of lamellar 
bodies and to synthesize lamellar bodies the keratinocyte 
must have abundant quantities of cholesterol, fatty acids and 
ceramides. These lipids could serve as signaling molecules and 
thereby coordinately regulate the formation of the stratum 
corneum. Fatty acids activate PPArs and studies have shown 
that PPAr activation stimulates keratinocyte differentiation. 
Cholesterol is converted to oxysterols that activate LXr 
and studies have shown that LXr activation also stimulates 
keratinocyte differentation. Additionally, PPAr and LXr 
activation also facilitates the formation of the lipid enriched 
lamellar membranes. Ceramides, via a number of mechanisms 
also stimulate keratinocyte differentiation. recently, studies 
have shown that ceramides by increasing PPAr delta also 
increase the expression of ABCA12, which would facilitate the 
formation of lamellar bodies. Finally, keratinocytes accumulate 
a large quantity of cholesterol sulfate, which plays a key role 
in regulating desquamation. Cholesterol sulfate has also 
been shown to stimulate keratinocyte differentiation. Thus, 
cholesterol, cholesterol sulfate, fatty acids and ceramides 
all stimulate keratinocyte differentiation and thereby could 
coordinately regulate the formation of the stratum corneum.
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Introduction
A major function of the epidermis is to provide a permeability 
barrier between the external environment and the organism.1,2 
A permeability barrier that prevents the excess loss of water and 
electrolytes is essential for life on land. To provide this permabil-
ity barrier, keratinocytes undergo a complex pathway of differ-
entiation, which culminates in keratinocyte cornification and in 
the formation of extracellular lipid-enriched lamellar membranes 
in the stratum corneum.3-5 These extracellular lipid-enriched 
membranes are primarily responsible for the permeability barrier 
to water and electrolyte transit.1,2 In parallel with lipid matrix 
formation, keratinocyte cornification occurs, a process character-
ized by extensive cross-linking of loricrin, involucrin and other 
structural proteins by transglutaminases, leading to the forma-
tion of the cornified envelope.3-5 This structure is essential not 
only for the mechanical strength of the skin, but it also serves as 
a scaffold for the deposition of the lamellar membranes.6,7 Thus, 
the stratum corneum is the end-product of two interdependent 
mechanisms that occur during keratinocyte differentiation; i.e., 
those that lead to the formation of the corneocytes (the “bricks”), 
and those that generate the extracellular lipid-enriched matrix 
(the “mortar”). Yet, despite its critical importance, the mecha-
nisms that coordinately regulate the parallel formation of the 
corneocytes and the extracellular lamellar membranes remain 
largely unknown.
The lipid-enriched extracellular lamellar membranes in the 
stratum corneum are derived from the exocytosis of lamellar 
body contents from the outermost stratum granulosum cells1,2 
(Fig. 1). To form lamellar bodies three families of lipids, spe-
cifically, cholesterol, phospholipids and glucosylceramides, are 
synthesized in large quantities within the stratum spinosum and 
stratum granulosum cells. Studies by our laboratory have dem-
onstrated that not only is the epidermis a very active site of lipid 
synthesis, but also that inhibition of either cholesterol, fatty acid, 
ceramide or glucosylceramide synthesis disrupts normal lamellar 
body formation and subsequently, permeability barrier homeosta-
sis.2 Moreover, cholesterol and fatty acids, along with ceramides 114  Dermato-Endocrinology  volume 3 issue 2
different genes. The nuclear hormone receptors 
are all characterized by a central DNA binding 
domain which targets the receptor to specific 
DNA sequences (response elements). The DNA 
binding domain is composed of two highly 
conserved zinc fingers that distinguish these 
nuclear receptors from other DNA binding pro-
teins. The C-terminal portion of the receptor 
includes the ligand binding domain which rec-
ognizes specific hormones, vitamins, retinoids 
or other lipophilic compounds. The interaction 
of a ligand with its specific receptor shifts the 
receptor to a transcriptionally active state which 
allows the DNA binding domain to regulate 
gene expression.
Recently, it has been recognized that endog-
enous intracellular lipids activate certain nuclear 
hormone receptors (i.e., PPARs, LXR and 
FXR).10 Whereas PPARs are activated by fatty 
acids and their metabolic products, LXRs are 
activated by certain oxysterol metabolites of cho-
lesterol while farnesoid-X receptor (FXR), which 
is not expressed in keratinocytes, is activated 
by bile acids. These receptors heterodimerize 
with RXR and bind to direct repeats separated 
by a variable number of spacer nucleotides.10,11 
The activation of these nuclear hormone receptors regulates the 
expression of many genes, thereby influencing a variety of cellular 
functions. The ability of these nuclear hormones to sense cellular 
lipid levels and subsequently to regulate gene expression has led 
to their designation as “liposensors.”10
PPARs and LXRs  
(For detailed information see ref. 10–14)
PPARa. PPARa is expressed in liver, heart, kidney, muscle 
and brown fat, as well as the epidermis and its appendages. This 
receptor is activated by unsaturated fatty acids, metabolites of 
fatty acids and farnesol (an isoprenoid formed during cholesterol 
synthesis), as well as by the fibrate class of drugs. Clofibrate, gem-
fibrozil and fenofibrate are drugs that activate PPARa and are 
widely used to treat dyslipidemias. PPARa is expressed in kerati-
nocytes and the epidermis and mRNA and protein levels increase 
during keratinocyte differentiation.
PPARb/D. PPARb/D is expressed ubiquitously and activated 
by fatty acids. Drugs that activate PPARb/D (for example GW 
1516) increase serum HDL while lowering serum triglyceride in 
obese rhesus monkeys. In keratinocytes and epidermis, PPARb/D 
is expressed at high levels, and its expression is not altered by dif-
ferentiation. Studies have shown that PPARb/D expression in the 
epidermis is increased by phorbol esters, hair plunking, wound-
ing and epidermal inflammation.
PPARg. PPARg is predominantly expressed in fat storing and 
synthesizing tissues, such as adipocytes, where it stimulates free 
fatty acid uptake, lipogenesis and differentiation. It is activated 
by prostaglandin J2, fatty acids and the thiazolidindione drugs 
and phospholipids, must be generated in the appropriate molar 
ratio or abnormal lamellar bodies are formed and permeability 
barrier dysfunction results.2 Additionally, these lipid precursors 
must be transported into lamellar bodies and recent studies have 
shown that ABCA12 plays an important role in the transport 
of glucosylceramides into lamellar bodies.2 The epidermis also 
produces large quantities of cholesterol sulfate and the catabolism 
of cholesterol sulfate by steroid sulfatase in the stratum corneum 
plays a key role in regulating desquamation.8
While the formation of the corneocytes and the extracellu-
lar lamellar membranes has been extensively studied as distinct, 
but independent processes, it is apparent that the formation of a 
normal stratum corneum that will provide competent permeabil-
ity barrier function requires the coordinated regulation of both 
processes. In this review we will discuss the various pathways 
by which the lipids that are required for lamellar body forma-
tion and stratum corneum function could also serve as signaling 
molecules and thereby coordinately regulate the formation of the 
stratum corneum (Fig. 2).
Nuclear Hormone Receptors
Differential control of gene expression is essential for tissue dif-
ferentiation and development. Lipophilic compounds, such as 
steroid hormones, thyroid hormones, vitamin D and retinoids, 
are potent regulators of differentiation and development, and 
their actions have been shown to be mediated by cytoplasmic/
nuclear receptors.9 These lipophilic compounds bind to their 
respective nuclear hormone receptors and then interact with 
DNA to induce or repress the expression of a large number of 
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AP-1 site of the involucrin promoter also abolished the ability 
of LXR activators to increase involucrin expression.17 Moreover, 
increased AP-1 DNA binding was observed in nuclear extracts 
from keratinocytes treated with LXR activators and there was an 
increase in Fra-1 and Jun D mRNA and protein levels.17,26 These 
results suggest that PPAR/LXR activation of AP-1 transcription 
maybe one pathway by which PPAR/LXR activators increase the 
expression of differentiation related proteins.
Activation of PPARs and LXRs Stimulates Lamellar 
Membrane Formation
As discussed in detail in previous reviews the formation of the 
lipid enriched lamellar membranes in the extracellular space of 
the stratum corneum is a complex process that requires a num-
ber of steps1,2 (Fig. 1). First, the keratinocyte requires sufficient 
cholesterol, phospholipids and glucosylceramides to form lamel-
lar bodies (note fatty acids are required for the formation of 
phospholipids and ceramides and ceramides are required for the 
formation of glucosylceramide). Second, the lipids must be trans-
ported into the lamellar bodies. Third the keratinocyte needs to 
secrete the lamellar bodies into the extracellular space of the stra-
tum corneum. Finally, the secreted phospholipid must be con-
verted to fatty acids and the secreted glucosylceramide must be 
metabolized to ceramides in order to form a mature competent 
lamellar membrane that provides a barrier to the movement of 
water and electrolytes.
Topical treatment with activators of PPARa, PPARb/D, 
PPARg and LXR increased cholesterol, fatty acid and ceramide 
synthesis in mouse epidermis.27 In human organotypic skin cul-
tures PPARa activators increased the expression of key enzymes 
required for lipid synthesis including serine-palmitoyltransfer-
ase, long chain acyl-CoA synthase and HMG-CoA synthase.28 
Additionally, PPARg, PPARb/D, and LXR activators increase 
the expression of GPAT3, the initial enzyme in the biosynthesis 
of triglycerides and phospholipids.29 One would anticipate that 
an increase in epidermal lipid synthesis would help provide the 
lipids necessary for keratinocytes to synthesize lamellar bodies.
(TZDs). PPARg is the key transcription factor 
required for the differentiation of fibroblasts 
into adipocytes. Drugs, such as troglitazone, 
pioglitazone and rosiglitazone, reduce insu-
lin resistance in patients with Type 2 diabe-
tes and improve glycemic control. PPARg is 
expressed in keratinocytes and epidermis, and 
keratinocyte/epidermal differentiation result in 
increases in PPARg mRNA levels.
LXR. Two genes encode LXR paralogues, 
which are differentially expressed (i.e., LXR a 
is abundantly expressed in liver, kidney, spleen, 
adrenal and intestine, while LXR-b expression 
is ubiquitous). Both isoforms are activated by 
the same oxysterol metabolites, and by non-
sterol compounds developed by the pharma-
ceutical industry (for example GW 3965 or 
TO-901317). Activation of LXR increases the 
reverse cholesterol transport pathway (i.e., movement of choles-
terol from peripheral cells to the liver for excretion into the bile). 
Both LXR a and b isoforms are present in human keratinocytes 
and fetal rat epidermis, but in mouse epidermis only LXR-b was 
detected.
Activation of PPARs and LXRs Stimulates 
Keratinocyte Differentiation
Treatment of cultured keratinocytes with activators of PPARa, 
PPARb/D, PPARg or LXR stimulated cornified envelope forma-
tion and increased the protein and mRNA levels of markers of 
keratinocyte differentiation, such as involucrin, filaggrin, loricrin 
and transglutaminase 1.14-22 This stimulation of keratinocyte dif-
ferentiation induced by PPAR and LXR activators was seen in 
both undifferentiated proliferating keratinocytes and in differen-
tiated keratinocytes (i.e., keratinocytes grown under high calcium 
conditions). Similar to the in vitro results, topical application of 
PPARa, PPARb/D, PPARg or LXR activators to mouse skin also 
stimulated keratinocyte differentiation.14,19,20,23-25 Moreover, in 
knock-out mice deficient in either PPARa, PPARb/D, PPARg or 
LXR, the respective activators did not induce the expression of 
these differentiation markers indicating that this stimulation was 
receptor mediated.14,19,20,23-25 Thus, as fatty acid levels increase in 
keratinocytes to allow for the synthesis of the lipids required for 
lamellar body formation one can hypothesize that these fatty acids 
would activate PPARs and thereby also stimulate keratinocyte dif-
ferentiation.2,14 Similarly, as cholesterol levels increase to provide 
for lamellar body synthesis one can speculate that this would 
lead to the increased production of oxysterols that activate LXR 
thereby also stimulating keratinocyte differentiation2,14 (Fig. 2).
The promoter regions of many of the genes that increase dur-
ing differentiation have AP-1 binding sites and their expression is 
known to be enhanced by increased AP-1 binding (for example 
involucrin, loricrin, transglutaminase 1). Studies have shown that 
deletions or mutations in the distal AP-1 site of the involucrin 
promoter prevented PPARa activators from increasing involu-
crin expression.16,24 Similarly, deletions or mutations in the distal 
Figure 2. regulation of lamellar membrane formation and keratinocyte differentiation by 
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barrier homeostasis. In the basal state where permeability barrier 
function is already ideal PPAR and LXR activators do not result 
in a reduction in transepidermal water loss, a sensitive measure 
of permeability barrier function.27 However, following acute per-
meability barrier disruption the restoration of permeability bar-
rier function was accelerated by PPAR and LXR activators.27 As 
discussed above there are a number of key steps in the formation 
of the competent lamellar membranes that mediate permeability 
barrier function and treatment with PPAR and LXR activators 
enhances these steps (Fig. 3). Thus, in addition to stimulating 
the formation of corneocytes (the “bricks”), activation of PPARs 
and LXRs also stimulates the formation of the extracellular lipid 
matrix (the “mortar”).
Cholesterol Sulfate
Cholesterol sulfate is very abundant in the epidermis with the 
highest levels in the granular layer and a progressive decline from 
inner to outer stratum corneum.2,8 A key role for cholesterol sul-
fate in desquamation has been demonstrated in X-linked ichthy-
osis, where a defect in the steroid sulfatase gene allows cholesterol 
sulfate levels to reach levels ten-fold higher than normal, resulting 
in abnormal corneocyte retention and a thickened stratum cor-
neum.8 In addition to its role in desquamation, cholesterol sulfate 
stimulates keratinocyte differentiation.34,35 Incubation of kerati-
nocytes with cholesterol sulfate has been shown to increase corni-
fied envelope formation and stimulate the expression of filaggrin, 
loricrin, involucrin and transglutaminases 1. Cholesterol sulfate 
stimulates keratinocyte differentiation via a number of different 
mechanisms, including the activation of protein kinase C and 
directly by affecting gene transcription.34,35 Thus, the increase in 
cholesterol sulfate levels in the epidermis could be a positive sig-
nal to further enhance keratinocyte differentiation.
Cholesterol sulfate is synthesized in the epidermis by the 
cytosolic enzyme cholesterol sulfotransferase. Recent studies 
have shown that cholesterol sulfotransferase type 2B isoform 
1b (SULT2B1b) is the isozyme that catalyzes the synthesis of 
ABCA12 facilitates the delivery of glucosylceramide into 
lamellar bodies and is required for lamellar body formation. 
PPARb/D, PPARg and LXR activators stimulate ABCA12 
expression in human keratinocytes in a dose and time depen-
dent manner.30 This increase in ABCA12 would facilitate the 
synthesis of lamellar bodies. Recent studies have suggested that 
ABCG1 may also play a role in the formation of lamellar bodies.31 
Moreover, PPAR and LXR activators increase the expression of 
ABCG1, which may facilitate lamellar body formation.31
Topical treatment of mice with PPARa, PPARb/D and LXR 
activators enhanced lamellar body secretion in both the basal 
state and after acute permeability barrier disruption.27 In contrast, 
topical treatment with activators of PPARg did not alter lamellar 
body secretion.27 Moreover, mice deficient in PPARb/D but not 
other PPARs or LXRs, have a decrease in lamellar body forma-
tion and secretion.32 Similarly, RXRa or RXRa/RXR b double 
knockout mice also demonstrate a defect in the lamellar body 
secretory system very similar to what is observed in PPARb/D 
deficient mice.33 Significantly, treatment of the RXR deficient 
mice with a PPAR b/D activator corrected the abnormalities in 
the lamellar body secretory system.33 These results suggest that 
PPARb/D may be the key PPAR isoform required for lamellar 
body formation and secretion. Moreover, these results indicate 
that activation of PPARs and LXRs could enhance lamellar body 
secretion.
The lipids in lamellar bodies are metabolized in the extracel-
lular spaces of the stratum corneum to form mature lamellar 
membranes.1,2 Of particular note glucosylceramide is converted 
to ceramide by the enzyme b-glucocerebrosidase. Topical treat-
ment of mouse epidermis with activators of PPARs and LXRs 
increase the activity of b-glucocerebrosidase.27 Additional, treat-
ment of human organotypic cultures have shown that PPARa 
activators increased b-glucocerebrosidase expression.28 This 
increase in enzyme activity would facilitate the extracellular 
lipid processing and enhance lamellar membrane formation.
Given the above results it is not surprising that topical treat-
ment with PPAR and LXR activators improves permeability 
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knockdown with siRNA attenuated the ability of ceramides to 
increase ABCA12 expression.42 Of note, PPARD knockdown 
did not affect the ability of ceramides to stimulate involucrin 
expression,42 which is likely accounted for by the ability of AP-1 
to directly stimulate involucrin expression. One can view the 
ceramide induced increase in ABCA12 expression as a feed for-
ward effect. As the keratinocyte produces increasing ceramides, 
which will be converted to glucosylceramides, the ceramides 
provide a signal to increase ABCA12 expression to facilitate the 
transport of glucosylceramides into lamellar bodies.
Conclusion
The formation of a normal functional stratum corneum requires 
both extracellular lipid membranes and corneocytes (“bricks and 
mortar”). In this review we describe a number of pathways by 
which the increasing quantities of lipids required for lamellar 
body synthesis and lamellar membrane formation could regulate 
corneocyte formation. In addition, we describe how the accumu-
lation of lipids could also regulate lipid metabolism to facilitate 
the formation of lamellar bodies. The formation of a normal 
stratum corneum is a complex process that must be precisely 
coordinated and it is likely that lipids play an important role in 
orchestrating this process.
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cholesterol sulfate in the epidermis/keratinocytes.36 SULT2B1b 
expression increases during calcium induced differentiation in 
parallel with an increase in cholesterol sulfotransferase activ-
ity.36,37 Moreover, PPAR and LXR activators increase SULT2B1b 
expression in both undifferentiated and differentiated kerati-
nocytes.37 Thus, increases in fatty acids and/or cholesterol via 
oxysterols could activate PPARs and LXRs and stimulate the 
expression of SULT2B1b leading to increased synthesis of cho-
lesterol sulfate, which would then further enhance keratinocyte 
differentiation (Fig. 2).
Ceramides
As keratinocytes differentiate ceramide production increases to 
provide the building blocks for lamellar body formation.1,2 Wakita 
and colleagues were the first to demonstrate that ceramides 
stimulate keratinocyte differentiation and inhibit proliferation.38 
Cornified envelope formation, involucrin expression and trans-
glutaminase activity are increased in keratinocytes treated with 
cell permeable ceramides.38-40 The mechanisms by which cerami-
des enhance keratinocyte differentiation are not fully understood 
but ceramides increase AP-1 activity39,41 and as noted earlier in 
this review many of the genes whose expression is increased dur-
ing keratinocyte differentiation contain AP-1 response elements 
in their promoters and their expression is stimulated by AP-1. 
Thus, increasing ceramide levels in differentiating keratinocytes 
could provide another signaling system to link lamellar mem-
brane formation (the “mortar”) with corneocyte formation (the 
“bricks”) (Fig. 2).
Recent studies have further shown that ceramides also 
increase ABCA12 expression in keratinocytes.42 Interestingly 
this stimulation of ABCA12 expression by ceramides is mediated 
via PPARD. Ceramides increased the expression of PPARD but 
not other PPARs or LXRs.42 This increase in PPARD expression 
is mediated by increased AP-1 activity.41,42 Moreover, PPARD 
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